These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 219976)

  • 21. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Simultaneous detection of IgM antibodies against the hepatitis A virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis].
    Naveau S; Delfraissy JF; Poitrine A; Poynard T; Chaput JC
    Gastroenterol Clin Biol; 1985 Feb; 9(2):109-12. PubMed ID: 2984075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unusual prevalence of Epstein-Barr virus early antigen (EBV-EA) antibodies in ataxia telangiectasia.
    Joncas J; Lapointe N; Gervais F; Leyritz M
    J Immunol; 1977 Nov; 119(5):1857-9. PubMed ID: 199670
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients.
    Masucci G; Berkel I; Masucci MG; Ernberg I; Szigeti R; Ersoy F; Sanal O; Yegin O; Henle G; Henle W
    J Clin Immunol; 1984 Sep; 4(5):369-82. PubMed ID: 6092413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
    Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
    J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
    Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.
    Jones JF; Williams M; Schooley RT; Robinson C; Glaser R
    Arch Intern Med; 1988 Sep; 148(9):1957-60. PubMed ID: 2843138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A familial syndrome of susceptibility to chronic active Epstein-Barr virus infection.
    Joncas JH; Ghibu F; Blagdon M; Montplaisir S; Stefanescu I; Menezes J
    Can Med Assoc J; 1984 Feb; 130(3):280-4. PubMed ID: 6318944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possible etiological relations between Sjogren's syndrome and Epstein-Barr virus].
    Yang J
    Zhonghua Yi Xue Za Zhi; 1991 Mar; 71(3):131-5, 10. PubMed ID: 1648423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease.
    Verschuuren E; van der Bij W; de Boer W; Timens W; Middeldorp J; The TH
    J Med Virol; 2003 Feb; 69(2):258-66. PubMed ID: 12683416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
    Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
    Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution to rapid diagnosis of infectious mononucleosis.
    Franková V; Stanková M; Kouba K; Hásková V; Pavlík E
    Acta Virol; 1986 May; 30(3):234-42. PubMed ID: 2874728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody against synthetic peptide derived from Epstein-Barr virus-determined nuclear antigen 1 (EBNA-1) in child non-Hodgkin's lymphoma.
    Sova P; Roubalová K; Weinreb M; Hamsíková E; Kodet R; Krchnák V; Roubal J
    Acta Virol; 1990 Apr; 34(2):132-8. PubMed ID: 1975974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr nuclear antigen (EBNA) carrying lymphocytes in human palatine tonsils.
    Veltri RW; McClung JE; Sprinkle PM
    J Gen Virol; 1976 Sep; 32(3):455-60. PubMed ID: 184241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to Epstein-Barr virus-associated nuclear antigen and to other viral and non-viral antigens in Hodgkin's disease.
    Rocchi G; Tosato G; Papa G; Ragona G
    Int J Cancer; 1975 Aug; 16(2):323-8. PubMed ID: 168161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis.
    Larsen PD; Bloomer LC; Bray PF
    Neurology; 1985 Mar; 35(3):435-8. PubMed ID: 2983262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus (EBV)-associated antibody patterns in relation to the deficiency of cell-mediated immunity in patients with Hodgkin's disease.
    Johansson B; Killander D; Holm G; Mellstedt H; Henle G; Henle W; Klein G; Söderberg G
    IARC Sci Publ (1971); 1975; (11 Pt 2):237-47. PubMed ID: 191367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfer factor therapy in ataxia--telangiectasia.
    Berkel AI; Ersoy F; Epstein LB; Spitler LE
    Clin Exp Immunol; 1977 Sep; 29(3):376-84. PubMed ID: 201409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.